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RESEARCH ARTICLE
Low level lead exposure and pregnancy 
outcomes in an observational birth cohort 
study: dose–response relationships
Caroline M. Taylor1* , Kate Tilling2, Jean Golding1 and Alan M. Emond1
Abstract 
Background: National and international guidelines on safe levels for blood Pb in pregnancy focus on a threshold 
above which exposure is of concern. However, it has recently been suggested that the decrease in birth weight per 
unit increase in blood Pb is actually greater at lower than at higher concentrations of Pb without evidence of a lower 
threshold of effect. Our aim was to investigate whether there was evidence for a differential effect of maternal Pb 
levels on birth outcomes and/or a threshold value for effects.
Methods: Blood samples from pregnant women enrolled in the Avon Longitudinal Study of Parents and Children 
(ALSPAC) were analysed. Data collected on the infants included anthropometric variables. We fitted adjusted multi-
variable fractional polynomial models for birth outcomes.
Results: Adjusted models that assumed a linear relationship between untransformed blood Pb and the outcomes 
provided the best fit: an increase of 1 µg/dl was associated with changes in birth weight of −9.93 (95 % CI −20.27, 
0.41) g, head circumference −0.03 (95 % CI −0.06, 0.00) cm and crown–heel length −0.05 (95 % CI −0.10, 0.00) cm.
Conclusion: There was no evidence in this study to suggest a supralinear dose–response relationship or a lower 
threshold for the effect of maternal blood Pb on birth outcomes. This has implications for consideration of national 
and international guidelines on levels of concern in pregnancy. Exposure to Pb should be kept as low as possible dur-
ing pregnancy to minimise adverse outcomes.
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Background
Lead (Pb) is a neurotoxic metal that is widespread in 
the environment. It readily crosses the placenta [1] and 
can have adverse effects on birth outcomes, possibly by 
accumulating in the placenta and causing reduced nutri-
ent transfer and oxidative stress and abnormal function 
[2, 3]. However, studies on the association of blood Pb 
(B-Pb) concentrations in pregnancy with birth outcomes 
have had inconsistent results at all levels of exposure [4–
7]. Poor birth outcomes are known to be associated with 
poor developmental trajectories throughout childhood, 
as well as with long-term implications for adult health, so 
the effects of Pb levels need to be characterised to ena-
ble delivery of appropriate public health policy and indi-
vidual healthcare to lead-exposed women and newborn 
infants.
National and international guidelines on for blood Pb 
focus on a threshold of concern, although the USA is 
the only country to publish reference values specifically 
for pregnant women [8]. It has recently been suggested, 
however, for Pb concentrations <10  µg/dl the deficit in 
birth weight per 1  µg/dl increase in B-Pb is greater at 
lower than at higher concentrations, without evidence of 
a lower threshold of effect [9]. This is of importance given 
the high prevalence of low level B-Pb exposure among 
pregnant women in developed countries [10–13] and the 
controversy regarding the recommended level of concern 
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for maternal B-Pb [8]. We have previously shown adverse 
effects of increased maternal B-Pb concentrations on 
birth outcomes, including birth weight, head circumfer-
ence and crown–heel length, in a large cohort of preg-
nant women in the UK (the Avon Longitudinal Study of 
Parents and Children, ALSPAC) using adjusted linear 
and logistic regression models [14]. Our aim in the pre-
sent study was to investigate whether there was evidence 
for a differential effect and/or a threshold value for effects 
on birth weight and other birth outcomes in the same 
cohort using multivariable fractional polynomials (mfp).
Methods
The ALSPAC study
The study sample was derived from the ALSPAC study, 
a population-based study investigating environmen-
tal and genetic influences on the health, behaviour and 
development of children. All pregnant women in the for-
mer Avon Health Authority with an expected delivery 
date between 1 April 1991 and 31 December 1992 were 
eligible for the study; 14,541 pregnant women were ini-
tially enrolled, resulting in a cohort of 14,062 live births 
[15]. The social and demographic characteristics of this 
cohort were similar to those found in UK national census 
surveys [16]. Further details of ALSPAC are available at 
http://www.bris.ac.uk/alspac. The study website contains 
details of all the data that are available through a fully 
searchable data dictionary (http://www.bris.ac.uk/alspac/
researchers/data-access/data-dictionary/).
Ethics approval
Ethics approval for the study was obtained from the 
ALSPAC Ethics and Law Committee and the Local 
Research Ethics Committees. Consent for questionnaire 
completion was implied if the questionnaire was com-
pleted and returned to the study office: there was no 
compulsion to do so, and no reward was given. Analyses 
of biological samples were only carried out with written 
permission.
Collection, storage and analysis of blood samples
Whole blood samples were collected in acid-washed 
vacutainers (Becton and Dickinson, Oxford, UK) by mid-
wives as early as possible in pregnancy. The median ges-
tational age at the time of blood sampling was 11 weeks 
(range 1–42  weeks, interquartile range 9–13  weeks). 
Whole blood samples were stored in the original tube at 
4 °C at the collection site before being transferred to the 
central Bristol laboratory within 1–4 days. Samples were 
at ambient temperature during transfer (up to 3 h). They 
were then stored at 4 °C in Bristol until analysis.
Samples were sent by courier to the Centers for Disease 
Control and Prevention (CDC) where they were analysed 
for lead using inductively coupled plasma mass spec-
trometry in standard mode by R. Jones (Bethesda, MD, 
USA; CDC Method 3009.1) as detailed in Golding, Steer, 
Hibbeln, Lowery and Jones [17]. The analyses were com-
pleted on 4284 women for Pb. One sample had a Pb level 
below the limit of detection (0.29 µg/dl): this sample was 
assigned a value of 0.7 times the lower limit of detection 
(LOD/√2) [18, 19].
Questionnaires
The mothers received postal self-completion question-
naires during pregnancy. The questionnaires are available 
from the study website (http://www.bristol.ac.uk/alspac/
researchers/resources-available/data-details/question-
naires/). Information on environmental and lifestyle fac-
tors included data on self-reported age, parity, highest 
educational qualification and cigarette smoking.
Pregnancy outcomes
Newborn head circumference and crown–heel length 
were measured by trained study staff where the mother 
gave permission or if these data were missing, the val-
ues were extracted from the medical records by trained 
study staff. Birth weight was derived from obstetric 
data and from central birth notification data: where 
values disagreed by <100  g then the lowest value was 
accepted; if the values disagreed by >100 g then the value 
was coded as missing. Study staff were blinded to the 
maternal B-Pb. Length of gestation was based on last 
menstrual period date, ultrasound assessment or other 
clinical indicators. Where there was conflict between 
the maternal report and ultrasound assessment, an expe-
rienced obstetrician reviewed the clinical records and 
made a best estimate.
Statistical analyses
A total of 4190 singleton live births were included. We 
fitted multivariable fractional polynomials for continu-
ous birth outcomes (birth weight, head circumference, 
crown–heel length). Fractional polynomials are a method 
for fitting more flexible polynomials than the usual simple 
polynomials, and involve selection from a set of polyno-
mial functions. Multivariable fractional polynomial fit-
ting is based on a closed-test procedure that maintains an 
overall type 1 error (alpha level) of 0.05 for tests among 
44 different combinations [20]. For each outcome, a set 
of potential confounders in addition to B-Pb are selected 
to enter the model; those that remain with a significance 
level of 0.2 are retained [20]. The confounders included: 
maternal educational attainment, smoking, gestational 
age (centred at 40 weeks), maternal height and pre-preg-
nancy weight, and sex of the infant. One or two terms of 
fractional polynomials were explored in terms of xp for 
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B-Pb, where the power p is chosen from −2, −1, −0.5, 
0.5, 1, 2, 3 and natural logarithmic transformation [20]. 
The models were repeated with the exclusion of B-Pb 
values >10.00 µg/dl to model the effects of relatively low 
exposure (n = 4175). Sensitivity analysis was conducted 
by excluding the upper and lower 5 % of B-Pb values. In 
addition, lowess (locally weighted scatterplot smoother) 
curves were fitted for the three outcomes: this method 
fits a smooth curve between two variables [21]. Statistical 
analysis was done using the mfp and lowess commands in 
Stata v. 13.
Results
The median B-Pb value was 3.40 (interquartile range 
2.66–4.33, range 0.20–19.14, n  =  4190)  µg/dl. The 
median value remained as 3.40 (interquartile range 
2.66–4.32, range 0.20–9.96, n = 4175) µg/dl when sam-
ples >10.00 µg/dl were excluded. The mothers providing 
a blood sample for Pb analysis were slightly older and had 
slightly higher educational attainment compared with 
the rest of the ALSPAC mothers cohort [22]. For all con-
tinuous birth outcomes, adjusted models that assumed a 
linear relationship between untransformed blood Pb and 
the outcomes provided the best fit; exclusion of values 
>10.00  µg/dl did not change the fit (all final mfp mod-
els: final powers 1) (Table  1; Fig.  1). Sensitivity analysis 
confirmed that models were robust (linear relationships 
confirmed; Table 1). Further confirmation was provided 
by the lowess curves, which were very similar to the mfp 
fits (Fig. 1).
Discussion
Estimated changes in birth weight, head circumference 
and crown–heel length with a 1 µg/dl change in blood Pb 
did not vary across the Pb distribution for the whole sam-
ple (values <20 µg/dl). Similar results were obtained for 
the subsample including values <10 µg/dl. Thus there was 
no evidence in this study to suggest a supralinear dose–
response relationship. There was no evidence to support 
a lower threshold for the effect of maternal B-Pb on these 
birth outcomes.
Although supralinear relationships have been noted 
in the relationship between Pb levels in children and 
intellectual development [23, 24], most studies that 
have modelled maternal B-Pb concentrations with 
birth outcomes have used multiple linear and/or logis-
tic regression to model linear relationships. To our 
knowledge, there is only a single study that has used 
multiple linear regression with fractional polynomials, 
which enables curves to be fitted, to assess continu-
ous birth outcomes [9]. Zhu et al. studied a population 
taken from the New York Heavy Metals Registry, which 
includes test reports on Pb concentrations from 
pregnant women aged 15–49 years living in New York 
State. Their sample included more than 44,000 live sin-
gleton births with a mean maternal Pb concentration 
of 2.1 µg/dl (median 2.0 µg/dl) reported to the registry 
in 2003–2005 (participants with values >10 µg/dl were 
excluded from the analyses). In contrast to our results, 
it was found that a model assuming a linear relation-
ship between the square root of the B-Pb fitted the 
data for birth weight better than any other combina-
tion of fractional polynomials evaluated: the estimated 
changes in birth weight with a 1 µg/dl change in B-Pb 
varied across the B-Pb distribution consistent with the 
supralinear shape of the dose–response curve. Thus, 
at the lower end of the distribution, a 1 unit change in 
B-Pb from 0 to 1 µg/dl was associated with a decrease 
on birth weight of 27  g, whereas a change from 9 to 
10  µg.dl was associated with a decrease of only 4.4  g. 
In the present study, the decrease was 9.93 g per 1 unit 
change at all concentrations of B-Pb, ranging from 
0.20 to 19.14 µg/dl. Repetition of the analyses with the 
exclusion of values >10  µg/dl to reflect effects of low 
exposure explored in the New York State cohort did 
Table 1 Associations between  maternal B-Pb and  birth 
outcomes modelled with adjusted multivariable fractional 
polynomial models in ALSPAC
mfp multivariable fractional polynomial
a Adjusted for maternal educational attainment, smoking, gestational age 
(centred at 40 weeks), maternal height and pre-pregnancy weight, and sex of 
the infant. 1, linear
b Exclusion of upper and lower 5 % of B-Pb values
n Unstandardised B 
regression coefficient 
(95 % confidence 
interval)
Fit in adjusted 
mfp model 
(final powers)a
Adjusted model
 Birthweight (g) 3096 −9.93 (−20.27, 0.41) 1
 Head circumference 
(cm)
2741 −0.03 (−0.06, 0.00) 1
 Crown–heel length 
(cm)
2706 −0.05 (−0.10, 0.00) 1
Adjusted model with  
exclusion of values >10 µg/dl
 Birthweight (g) 3084 −11.07 (−22.12, 0.18) 1
 Head circumference 
(cm)
2732 −0.04 (−0.07, 0.00) 1
 Crown-heel length 
(cm)
2697 −0.06 (−0.11, 0.00) 1
Adjusted model for  
sensitivity analysisb
 Birthweight (g) 2785 −8.16 (−18.97, 2.65) 1
 Head circumference 
(cm)
2466 −0.04 (−0.08, 0.01) 1
 Crown–heel length 
(cm)
2436 −0.08 (−0.15, 0.00) 1
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not change the fit of our models. There are several pos-
sible explanation for this difference in findings. First, 
the New York State cohort study was able to include 
a far greater number of participants than in our study 
(45,000 vs 4190 respectively). Second, there are several 
differences in the population samples. Whereas our 
study broadly reflected that of the UK population [16], 
the New York sample included participants who were 
more likely to be screened because of being at risk for 
adverse pregnancy outcome or lead exposure. In addi-
tion, the New York sample included a high proportion 
of African American women, whereas our sample was 
predominantly white (about 97  % of mothers provid-
ing a blood sample for analysis were white [22]), and 
the B-Pb values were slightly lower (median 2.0  µg/dl 
compared with median 3.4 µg/dl in the present study). 
Despite these differences, like Zhu et al. we did not find 
any evidence of a lower threshold of effect.
There are several limitations to this study, which have 
been described in detail previously [14]. In brief, these 
include possible sample bias and the inability to take all 
confounders into account. In addition, the deficits in the 
birth outcomes are relatively small, and for birth weight, 
the confidence interval were wide and included zero, sug-
gesting that there could be no overall association using 
this type of statistical analysis and that the power was 
relatively low.
Conclusion
There was no evidence to suggest a supralinear dose–
response relationship between maternal B-Pb and 
birth outcomes. As there was no evidence to suggest 
a lower threshold for the effect of maternal B-Pb on 
birth outcomes in this study, exposure to Pb should be 
kept as low as possible during pregnancy to minimise 
adverse outcomes. These results are of importance in 
Fig. 1 Model-based dose–response relationships between maternal B-Pb levels and birth weight (a), head circumference (b) and crown–heel 
length (c) fitted using multivariable fractional polynomials (mfp) and lowess smoothing curves. The mfp models were adjusted for maternal educa-
tional attainment, smoking, gestational age (centred at 40 weeks), maternal height and pre-pregnancy weight, and sex of the infant. a Birth weight, 
b head circumference, c crown–heel length
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the consideration of the levels of concern in pregnancy. 
Investigations in other cohorts are needed.
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